Cargando…

Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic

Detalles Bibliográficos
Autor principal:	Choy, Kay Weng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837007/ https://www.ncbi.nlm.nih.gov/pubmed/33521724 http://dx.doi.org/10.1016/S2666-5247(20)30168-3

Ejemplares similares

Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank
por: Ta, Lisa, et al.
Publicado: (2018)

Laboratory Safety and Biohazards
por: Ribes, Ramón, et al.
Publicado: (2009)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
por: Robilotti, Elizabeth, et al.
Publicado: (2023)

Mitigating the risks of surgery during the COVID-19 pandemic
por: Myles, Paul S, et al.
Publicado: (2020)

Bottlenecks and opportunities for synthetic biology biosafety standards
por: Pei, Lei, et al.
Publicado: (2022)

Hiroshima to Fukushima: biohazards of radiation
por: Ochiai, Eiichiro
Publicado: (2014)

Biohazard Accidents, Harmful Elements to the Wellness of Healthcare Workers, and Their Risk Factors
por: Tejada-Pérez, Juan José, et al.
Publicado: (2022)

Laboratory Biosafety and Good Laboratory Practices
por: Nambisan, Padma
Publicado: (2017)

Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory
por: Wang, Qin, et al.
Publicado: (2016)

Assessment of biosafety implementation in clinical diagnostic laboratories in Pakistan during the COVID-19 pandemic
por: Sarwar, Samreen, et al.
Publicado: (2022)

Biosafety in microbiological and biomedical laboratories /
Publicado: (1984)

A small contribution to mitigate the collision of transmissible and chronic diseases, exemplified by the management of hypertension during the COVID-19 pandemic
por: Valdés, Gloria, et al.
Publicado: (2020)

AA amyloid in human food chain is a possible biohazard
por: Rising, Anna, et al.
Publicado: (2021)

Perception of biohazards: a focus on schools in Western Attica, Greece
por: Papavasileiou, Christina, et al.
Publicado: (2021)

Increasing the biosafety of analytical systems in the clinical laboratory
por: Truchaud, A., et al.
Publicado: (1994)

Take action to mitigate the impact of the COVID-19 pandemic on HIV prevention and control
por: Yan, Xiangyu, et al.
Publicado: (2023)

Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks
por: Peng, Huasong, et al.
Publicado: (2018)

Laboratory biosafety for handling emerging viruses
por: Artika, I. Made, et al.
Publicado: (2017)

How will country-based mitigation measures influence the course of the COVID-19 epidemic?
por: Anderson, Roy M, et al.
Publicado: (2020)

Strengthening laboratory biosafety in Liberia during the COVID-19 pandemic: Experience from the Global Laboratory Leadership Programme
por: Malik, Shruti, et al.
Publicado: (2022)

Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries
por: Dexter, Daniel, et al.
Publicado: (2020)

Preparedness of community-based organisations in biohazard: reliability and validity of an assessment tool
por: Rezaei, Fatemeh, et al.
Publicado: (2019)

General biosafety measures for laboratory environments, outpatient clinics, medical centers, and veterinary hospitals during the SARS-CoV-2 pandemic
por: Ulsenheimer, Bruna Carolina, et al.
Publicado: (2022)

SINS model in the management of biosafety level 2 laboratories: exploration and practice
por: Qiu, Xiaoxia, et al.
Publicado: (2019)

Anthroponotic risk of SARS-CoV-2, precautionary mitigation, and outbreak management
por: Edwards, Sarah J L, et al.
Publicado: (2020)

Suicide risk and prevention during the COVID-19 pandemic
por: Gunnell, David, et al.
Publicado: (2020)

Diabetic ketoacidosis risk during the COVID-19 pandemic
por: Vellanki, Priyathama, et al.
Publicado: (2021)

Crowdsourcing data to mitigate epidemics
por: Leung, Gabriel M, et al.
Publicado: (2020)

Laboratory-acquired SARS raises worries on biosafety
por: Orellana, Claudia
Publicado: (2004)

Laboratory biosafety in China: past, present, and future
por: Wu, Guizhen
Publicado: (2019)

Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020)

Basic Scholarship in Biosafety Is Critically Needed To Reduce Risk of Laboratory Accidents
por: Ritterson, Ryan, et al.
Publicado: (2017)

Environmental Risk and Assessment Management System of High-level Biosafety Laboratory
por: Feng, Ding, et al.
Publicado: (2011)

Mitigating losses: how scientific organisations can help address the impact of the COVID-19 pandemic on early-career researchers
por: López-Vergès, Sandra, et al.
Publicado: (2021)

UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic
por: Weaver, Davis T., et al.
Publicado: (2021)

Mitigating bias in machine learning for medicine
por: Vokinger, Kerstin N., et al.
Publicado: (2021)

Motivating actions to mitigate plastic pollution
por: Jia, Lili, et al.
Publicado: (2019)

The importance for tuberculosis of mitigating economic crises
por: Rasella, Davide, et al.
Publicado: (2022)

Lessons Learned From a COVID-19 Biohazard Spill During Swabbing at a Quarantine Facility
por: Mayer, Oren, et al.
Publicado: (2020)

Enterovirus D68: a test case for the use of immunological surveillance to develop tools to mitigate the pandemic potential of emerging pathogens
por: Nguyen-Tran, Hai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v0f3jq4erdg8g5t7cdmvrsoh0b